Investors seeking early visibility into a broad set of life-sciences catalysts will have a direct line to management teams on September 17, 2026, when the Life Sciences Virtual Investor Forum convenes online. The event, hosted by Virtual Investor Conferences and marketed by B2i Digital, Inc., will feature seven companies presenting 30-minute live sessions with audience Q&A and on-demand replays.
The lineup is notable for its scientific breadth. Sona Nanotech Inc. is advancing a photothermal cancer therapy built on gold nanorods. Raphael Pharmaceutical is developing cannabinoid-based formulations for rheumatoid arthritis, chronic lung inflammation, and autoimmune disease. Amplia Therapeutics Ltd. is focused on a pipeline of Focal Adhesion Kinase inhibitors for cancer and fibrosis. Adaptin Bio, Inc. is pursuing precision drug delivery technologies aimed at target tissues, including behind the blood-brain barrier. Acurx Pharmaceuticals, Inc. is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens. CytoDyn Inc. is studying a humanized monoclonal antibody in solid-tumor oncology. 4DMedical Ltd. offers FDA-cleared four-dimensional respiratory imaging.
The forum matters because it compresses a wide range of therapeutic areas into a single day, allowing investors to compare management teams and hear unscripted responses to questions that filings rarely address. David Shapiro, Chief Executive Officer of B2i Digital, Inc., said, "Reading company filings is a great cure for insomnia, but if you want to stay awake and hear it directly from management, these conferences are the best way to get a real feel for the company. My favorite part is the Q&A and hearing how they handle the impromptu questions that are really on your mind."
Event details and presenting company profiles are available at https://b2idigital.com/sept-17-life-sciences-virtual-investor-forum. Investors can register at https://www.virtualinvestorconferences.com/wcc/eh/4814904/category/150412/september-17th-life-sciences-virtual-investor-forum?utm_source=b2i&utm_medium=marketing&utm_campaign=0917SeptLifeScienceVIC. Replays will be available on the B2i Digital and OTC Markets YouTube channels.
The presenting companies span multiple exchanges, reflecting the global nature of the Virtual Investor Conferences platform, which features public companies from NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and OTC Markets. Virtual Investor Conferences is an OTC Markets Group Inc. property. B2i Digital, Inc. is the Official Marketing Partner and is not an affiliate of Virtual Investor Conferences. The marketing partner has not independently verified company-provided information, and the event does not constitute an offer to buy or sell any security.
For investors, the forum offers a rare opportunity to assess management teams across oncology, fibrosis, drug delivery, antibiotics, cannabinoid therapeutics, and respiratory imaging in one sitting. The live Q&A format may surface details that are not in press releases, and the on-demand replays allow for deeper review. More information about B2i Digital's Featured Conference, Featured Company, and Featured Expert programs is available at https://b2idigital.com.
